Physician profile
Ester Avero
NPI 1215576467
$2,642.84
in general payments reported to CMS, 2019-2025
17 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.50 · 2022: $228 · 2023: $409 · 2024: $289 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,015 · Travel and Lodging: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,015.02 |
| Travel and Lodging | $360.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $557.52 | 2022-2025 | Apretude |
| Medical Device Business Services, INC. | $553.05 | 2025 | Harmonic |
| Mayne Pharma Commercial LLC | $243.71 | 2025 | |
| Hologic Sales and Service, LLC | $214.87 | 2024-2025 | Novasure, Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $204.87 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $198.35 | 2025 | Slynd, Twirla |
| Pfizer INC. | $150.25 | 2024-2025 | |
| Biogen, INC. | $136.64 | 2025 | Zurzuvae |
| Glaxosmithkline, LLC. | $105.88 | 2022-2023 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $97.83 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $49.33 | 2024 | |
| Dynavax Technologies Corporation | $29.84 | 2023 | Heplisav-B |
| Organon LLC | $24.38 | 2025 | Nexplanon |
| Lilly USA, LLC | $22.96 | 2025 | Zepbound |
| Novo Nordisk INC | $20.40 | 2024 | Rybelsus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $19.20 | 2025 | Cequr Simplicity |
| Phadia US INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ester Avero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.